FDA wants more details on Venaxis' new ER diagnostic technology

Venaxis Inc. needs to submit more information about its appendicitis diagnostic device to the U.S. Food and Drug Administration, which could delay regulatory approval of it in the U...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.